Literature DB >> 21509908

Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.

Stephan R Vavricka1, Sabrina M Spigaglia, Gerhard Rogler, Valérie Pittet, Pierre Michetti, Christian Felley, Christian Mottet, Christian P Braegger, Daniela Rogler, Alex Straumann, Peter Bauerfeind, Michael Fried, Alain M Schoepfer.   

Abstract

BACKGROUND: The diagnosis of inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), continues to present difficulties due to unspecific symptoms and limited test accuracies. We aimed to determine the diagnostic delay (time from first symptoms to IBD diagnosis) and to identify associated risk factors.
METHODS: A total of 1591 IBD patients (932 CD, 625 UC, 34 indeterminate colitis) from the Swiss IBD cohort study (SIBDCS) were evaluated. The SIBDCS collects data on a large sample of IBD patients from hospitals and private practice across Switzerland through physician and patient questionnaires. The primary outcome measure was diagnostic delay.
RESULTS: Diagnostic delay in CD patients was significantly longer compared to UC patients (median 9 versus 4 months, P < 0.001). Seventy-five percent of CD patients were diagnosed within 24 months compared to 12 months for UC and 6 months for IC patients. Multivariate logistic regression identified age <40 years at diagnosis (odds ratio [OR] 2.15, P = 0.010) and ileal disease (OR 1.69, P = 0.025) as independent risk factors for long diagnostic delay in CD (>24 months). In UC patients, nonsteroidal antiinflammatory drug (NSAID intake (OR 1.75, P = 0.093) and male gender (OR 0.59, P = 0.079) were associated with long diagnostic delay (>12 months).
CONCLUSIONS: Whereas the median delay for diagnosing CD, UC, and IC seems to be acceptable, there exists a long delay in a considerable proportion of CD patients. More public awareness work needs to be done in order to reduce patient and doctor delays in this target population.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509908     DOI: 10.1002/ibd.21719

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  71 in total

Review 1.  Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.

Authors:  Anet A Soubières; Andrew Poullis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

2.  Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.

Authors:  J Dhaliwal; T D Walters; D R Mack; H Q Huynh; K Jacobson; A R Otley; J Debruyn; W El-Matary; C Deslandres; M E Sherlock; J N Critch; K Bax; E Seidman; P Jantchou; A Ricciuto; M Rashid; A M Muise; E Wine; M Carroll; S Lawrence; J Van Limbergen; E I Benchimol; P Church; A M Griffiths
Journal:  J Crohns Colitis       Date:  2020-05-21       Impact factor: 9.071

3.  Diagnostic delay in patients with inflammatory bowel disease in Austria.

Authors:  Gottfried Novacek; Hans Peter Gröchenig; Thomas Haas; Heimo Wenzl; Pius Steiner; Robert Koch; Thomas Feichtenschlager; Gerald Eckhardt; Andreas Mayer; Andreas Kirchgatterer; Othmar Ludwiczek; Reingard Platzer; Pavol Papay; Johanna Gartner; Harry Fuchssteiner; Wolfgang Miehsler; Paul-Gerhard Peters; Gerhard Reicht; Harald Vogelsang; Clemens Dejaco; Thomas Waldhör
Journal:  Wien Klin Wochenschr       Date:  2019-02-04       Impact factor: 1.704

4.  Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.

Authors:  James R Irwin; Emma Ferguson; Lisa A Simms; Katherine Hanigan; James D Doecke; Daman Langguth; Ashley Arnott; Graham Radford-Smith
Journal:  Dig Dis Sci       Date:  2018-11-26       Impact factor: 3.199

5.  Diagnostic Delay in Crohn's Disease: Time for Red Flags.

Authors:  Gionata Fiorino; Silvio Danese
Journal:  Dig Dis Sci       Date:  2016-09-16       Impact factor: 3.199

Review 6.  Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis.

Authors:  Ekaterina Safroneeva; Alex Straumann; Alain M Schoepfer
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-01

7.  Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.

Authors:  Edward L Barnes; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2018-02       Impact factor: 10.864

8.  Time between suspected and confirmed diagnoses of Crohn's disease and ulcerative colitis in patients followed in gastroenterological practices in Germany.

Authors:  Karel Kostev; Marcel Konrad; Louis Jacob
Journal:  Int J Colorectal Dis       Date:  2018-05-02       Impact factor: 2.571

9.  Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.

Authors:  Alexander C Ford; Paul Moayyedi; Premysl Bercik; David G Morgan; Carolina Bolino; Maria I Pintos-Sanchez; Walter Reinisch
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

Review 10.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.